Tag: distribution

September 3, 2020

CNS PHARMACEUTICALS AG, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, today provides an update on progress for the U.S. manufacturing […]

August 28, 2020

AstraZeneca has been on roll lately, inking COVID-19 vaccine supply deals left and right with countries worldwide. One of its highest-profile pacts—a purchase deal with the European Union—was made official earlier this month, and now, the trading bloc has floated […]

July 28, 2020

With just over three months before the U.S. elections in November, President Donald Trump is making a last-ditch effort to stamp his name on a drug pricing deal that has eluded him over his first three years in office. A […]

July 14, 2020

In hopes of a late-stage COVID-19 vaccine candidate hitting the 50% efficacy threshold set by the U.S. Food and Drug Administration, U.S. drugmakers who have partnered with the U.S. government could begin to manufacture doses of a preventative treatment by […]

June 17, 2020

Vaccines normally take years to test and mass produce; the European Union, like the U.S., is trying to shrink that timeframe to 12 to 18 months. In addition to providing financial help to companies who are ramping up production before […]

June 15, 2020

FDA has revoked the emergency use authorization (EUA) for hydroxychloroquine sulfate (HCQ) and chloroquine phosphate (CQ) as treatments for COVID-19, according to a June 15, 2020 announcement. In a statement on its website, the agency noted that it “has determined […]

May 8, 2020

The global biotechnology market is mainly driven by the surge in the demand for food, depleting natural resources, government regulatory support, and technological advancements of various solutions to counter fatal diseases. The advent of stem cell technology, nanotechnology, and cloning […]

April 2, 2020

In adding manufacturing capacity—whether through new, greenfield sites or by refitting existing spaces—biopharma and pharma companies seek flexible and efficient production. Getting a facility up and running quickly with a tight budget is increasingly important. Flexibility is crucial in biopharmaceutical […]

March 26, 2020

How drugs are manufactured and distributed is a complicated global supply chain, with numerous drugs and their component parts manufactured in other countries. Research firm GlobalData issued a statement that the COVID-19 pandemic threatens biopharma in-house manufacturing. Pointing at China, […]

March 13, 2020

A bill to encourage the manufacture of active pharmaceutical ingredients in America was introduced in the U.S. Senate Tuesday by Senators Marsha Blackburn (R- TN) and Bob Menendez (R- NJ). It was read and referred to the Committee on Health, […]

March 12, 2020

Advaite, an innovative biotech company focused on developing novel diagnostics, announced today that it will begin supplying the global market with its COVID-19 rapid response diagnostic testing kits, ADVAITE RAPCOV, to help efforts to contain the spread of COVID-19 virus […]

March 11, 2020

The FDA and the FTC said they will crack down quickly on people trying to take advantage of consumers concerned about the coronavirus infection outbreak. An “aggressive surveillance program” is monitoring social media, online marketplaces and complaints from consumers, they […]

March 4, 2020

Acthar was first approved in 1952 for the treatment of rheumatoid arthritis, but its acquisition by Questcor from the former Aventis in 2001 allowed the new owner to test out a strategy of label expansions and steep price rises. In […]

February 28, 2020

Virus containment measures imposed by the Chinese government have resulted in shutdowns or partial closures at manufacturing plants in Wuhan, the province in which the new coronavirus emerged, as well as other nearby areas. For the drug industry, sustained reductions […]